Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor.
Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor.
复制标题
DOI:
10.1002/anie.202203225
复制
发表时间:
2022-08-01
影响因子:
16.6
通讯作者:
Kurosu, Michio
中科院分区:
文献类型:
--
作者:
Mitachi, Katsuhiko;Mingle, David;Effah, Wendy;Sanchez-Ruiz, Antonio;Hevener, Kirk E.;Narayanan, Ramesh;Clemons, William M., Jr.;Sarabia, Francisco;Kurosu, Michio
A short total synthesis of tunicamycin V (1), a nonselective phosphotransferase inhibitor, is achieved via a Büchner-Curtius-Schlotterbeck type reaction. Tunicamycin V can be synthesized in 15 chemical steps from D-galactal with 21% overall yield. The established synthetic scheme is operationally very simple and flexible to introduce building blocks of interest. The inhibitory activity of one of the designed analogues 28 against human dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 (DPAGT1) shows 12.5-times greater than 1. While tunicamycins are cytotoxic molecules with a low selectivity, the novel analogue 28 displays selective cytostatic activity against breast cancer cell lines including a triple-negative breast cancer. A Büchner–Curtius–Schlotterbeck-type reaction enabled the total synthesis of tunicamycin V (TN-V), a nonselective phosphotransferase inhibitor, in just 15 steps from D-galactal in 21% overall yield. The short and high-yielding synthetic route was also adapted for the synthesis of analogues, thus leading to the discovery of a novel cytostatic tunicamycin analogue, TN-TMPA, with high DPAGT1 selectivity.
登录
查看更多内容
影响因子:
4.8
作者:
Doerr, ME;Jones, JI
通讯作者:
Jones, JI
影响因子:
15
作者:
GEMAL, AL;LUCHE, JL
通讯作者:
LUCHE, JL
影响因子:
1.8
作者:
Collins, Tony J.;Ylanko, Jarkko;Andrews, David W.
通讯作者:
Andrews, David W.
影响因子:
5.2
作者:
Glibstrup, Emil;Pedersen, Christian Marcus
通讯作者:
Pedersen, Christian Marcus
影响因子:
15
作者:
Aggarwal, VK;Charmant, JPH;Winn, CL
通讯作者:
Winn, CL